Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Baum

Showing results (11-20 of 136) with videos related to

Pageof 14
Sort By:
Immunitat Und Infektion|February 1, 1989
[Immunoscintigraphy with radionuclide-labeled monoclonal antibodies for tumor diagnosis and in benign diseases]R P Baum, A Hertel, G Hör
Current Radiopharmaceuticals|August 1, 2012
Radionuclide generators - a new renaissance in the development of technologies to provide diagnostic and therapeutic radioisotopes for clinical applicationsF F Russ Knapp, R P Baum
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 10, 2004
Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancerR P Baum, D Hellwig, M Mezzetti
Der Gynakologe|February 1, 1989
[Immunoscintigraphic diagnosis in the after-care of gynecologic cancers]R P Baum, A Hertel, G Hör
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2020
Therapy-related myeloid neoplasm after peptide receptor radionuclide therapy (PRRT) in 1631 patients from our 20 years of experiences: prognostic parameters and overall survivalM Chantadisai, H R Kulkarni, R P Baum
Nuklearmedizin. Nuclear Medicine|June 1, 1990
[In vitro and in vivo effect of thyroid hormones on the growth of neuroblastoma cells. II. The effect of thyroxine in vivo]E Busse, R P Baum, G Hör, et al.
Der Urologe. Ausg. A|March 1, 1993
[Immunoscintigraphy in inflammatory and malignant diseases. anti-leukocyte and anti-tumor antibodies]W Kramer, R P Baum, G Hör, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 21, 2007
Receptor PET/CT imaging of neuroendocrine tumorsR P Baum, V Prasad, M Hommann, et al.
Nuklearmedizin. Nuclear Medicine|June 1, 1988
[Detection of the binding of 131I-meta-iodobenzylguanidine to structures of the plasma membranes of neuroblastoma cell lines]E Busse, R P Baum, G Hör, et al.
Anticancer Research|September 2, 1999
Diagnostic accuracy and predictive value of the tumor-associated antigen S100 in malignant melanomas: validation by whole body FDG-PET and conventional diagnosticsS Mruck, R P Baum, D Rinne, et al.
Pageof 14

Showing results (11-20 of 136) with videos related to

Sort By:
Pageof 14
Immunitat Und Infektion|February 1, 1989
[Immunoscintigraphy with radionuclide-labeled monoclonal antibodies for tumor diagnosis and in benign diseases]R P Baum, A Hertel, G Hör
Current Radiopharmaceuticals|August 1, 2012
Radionuclide generators - a new renaissance in the development of technologies to provide diagnostic and therapeutic radioisotopes for clinical applicationsF F Russ Knapp, R P Baum
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 10, 2004
Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancerR P Baum, D Hellwig, M Mezzetti
Der Gynakologe|February 1, 1989
[Immunoscintigraphic diagnosis in the after-care of gynecologic cancers]R P Baum, A Hertel, G Hör
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2020
Therapy-related myeloid neoplasm after peptide receptor radionuclide therapy (PRRT) in 1631 patients from our 20 years of experiences: prognostic parameters and overall survivalM Chantadisai, H R Kulkarni, R P Baum
Nuklearmedizin. Nuclear Medicine|June 1, 1990
[In vitro and in vivo effect of thyroid hormones on the growth of neuroblastoma cells. II. The effect of thyroxine in vivo]E Busse, R P Baum, G Hör, et al.
Der Urologe. Ausg. A|March 1, 1993
[Immunoscintigraphy in inflammatory and malignant diseases. anti-leukocyte and anti-tumor antibodies]W Kramer, R P Baum, G Hör, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 21, 2007
Receptor PET/CT imaging of neuroendocrine tumorsR P Baum, V Prasad, M Hommann, et al.
Nuklearmedizin. Nuclear Medicine|June 1, 1988
[Detection of the binding of 131I-meta-iodobenzylguanidine to structures of the plasma membranes of neuroblastoma cell lines]E Busse, R P Baum, G Hör, et al.
Anticancer Research|September 2, 1999
Diagnostic accuracy and predictive value of the tumor-associated antigen S100 in malignant melanomas: validation by whole body FDG-PET and conventional diagnosticsS Mruck, R P Baum, D Rinne, et al.
Pageof 14